HIV-1 proviral DNA load across neuroanatomic regions of individuals with evidence for HIV-1-associated dementia

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 16, Issue 3, 1997, Pages 146-152

  Fujimura, Robert K ^a   Goodkin, Karl ^a,b   Petito, Carol K ^a   Douyon, Richard ^a,c   Feaster, Daniel J ^a   Concha, Mauricio ^a   Shapshak, Paul ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Department of Biology   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

HIV 1; HIV 1 encephalitis; HIV 1 associated dementia; Neuroanatomic regions; Proviral DNA load; Quantitative PCR

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; AUTOPSY; BRAIN REGION; DEMENTIA; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEUROANATOMY; NEUROPATHOLOGY; NEUROPSYCHIATRY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROVIRUS; QUANTITATIVE DIAGNOSIS; VIRUS DIAGNOSIS; VIRUS ENCEPHALITIS;

EID: 0030716168     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199711010-00002     Document Type: Article

References (38)

1. Goodkin K. Complications of the central and peripheral nervous systems. In: M. Forstein, ed. HIV-related neuropsychiatric complications and treatments: HIV/AIDS training curriculum. Washington DC: American Psychiatric Association, 1995:1-103.
2. Goodkin K. Neuropsychiatric and behavioral aspects of HIV spectrum disease, section IX. In: Clinical manual on HIV and AIDS. Tallahassee, FL: Florida Medical Association Committee on AIDS, 1995:113-31.
3. Snider WD, Simpson DM, Nielsen S, Gold JWM, Metroka CE, Posner JB. Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol 1983;14: 403-18.
4. Navia BA, Jordan BD, Price RW. The AIDS dementia complex. I. Clinical features. Ann Neurol 1986;19:517-24.
5. Portegies P. AIDS dementia complex: a review. J Acquir Immune Defic Syndr Hum Retrovirol 1994;7:S38-49.
6. Goodkin K, Shapshak P, Fujimura RK, et al. Immune function, brain, and HIV-1 infection. In: Goodkin K, Visser APH, eds. Psychoneuroimmunology: stress, mental disorders and health. Washington, DC: American Psychiatric Press, 1998, in press.
7. Black RJ, Rausch DM. NeuroAIDS, current understanding and future directions. J Neurovirol 1996;2:230-3.
8. Budka H, Wiley CA, Kleihues P, et al. HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol 1991;1:143-52.
9. Brew BJ, Rosenblum M, Cronin K, Price RW. AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations. Ann Neurol 1995;38:563-70.
10. Kure K, Weidenheim KM, Lyman WD, Dickson DW. Morphology and distribution of HIV-1-positive microglia in subacute AIDS encephalitis: pattern of involvement resembling a multisystem degeneration. Acta Neuropathol (Berl) 1990;80:393-400.
11. Masliah E. Achim CL, Ge N, DeTeresa R, Wiley CA. Cellular neuropathology in HIV encephalitis. In: RW Price, Perry SW, eds. HIV, AIDS and the brain. New York: Raven Press, 1994:119-31.
12. Petito CK, Cho E-S, Lemann W, Navia BA, Price RW. Neuropathology of acquired immunodeficiency syndrome (AIDS): autopsy review. J Neuropathol Exp Neurol 1986;45:635-46.
13. Brew BJ. The pathogenesis of the neurological complications of HIV-1 Infection. Genitourin Med 1993;69:333-40.
14. Yoshioka M, Shapshak P, Sun NCJ, et al. Simultaneous detection of ferritin and HIV-1 in reactive microglia. Acta Neuropathol 1992;84:297-306.
15. Glass JD, Wesselingh SL, Selnes OA, McArthur JC. Clinical-neuropathologic correlation in HIV-associated dementia. Neurology 1993;43:2230-7.
16. Glass JD, Fedor H, Wesselingh SL, McArthur JC. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 1995;38:755-62.
17. Wiley CA, Achim C. Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome. Ann Neurol 1994;36:673-6.
18. Fujimura RK, Bockstahler LE, Goodkin K, Werner T, Brack-Werner R, Shapshak P. Neuropathology and virology of HIV associated dementia. Rev Med Virol 1996;6:141-50.
19. Fujimura RK, Bockstahler LE. PCR method for determining ratios of HIV proviral DNA to cellular genomic DNA in brain tissue of HIV-infected patients. J Virol Methods 1995;55:309-25.
20. Fujimura RK, Shapshak P, Feaster D, Epler M, Goodkin K. A rapid method for comparative quatitiative polymerase chain reaction of HIV-1 proviral DNA extracted from cryopreserved brain tissues. J Virol Methods 1997;67:177-87.
21. Shapshak P, Yoshioka M, Sun NCJ, et al. HIV-1 in postmortem brain tissue from patients with AIDS: a comparison of-different detection techniques. AIDS 1992;6:915-23.
22. Nagano I, Shapshak P, Yoshioka M, Xin KQ, Nakamura S, Bradley WG. Increased NADPH-diaphorase reactivity and cytokine expression in dorsal root ganglia in AIDS. J Neurol Sci 1996; 136:117-28.
23. Shapshak P, Yoshioka M, Sun NCJ, Schiller P. The use of combined in situ hybridization and immunocytochemistry to identify HIV-infected cells in brain tissue. Mod Pathol 1992;5:649-4.
24. American Academy of Neurology AIDS Task Force Working Group. Nomenclature and research definition for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) in-fection. Neurology 1991;41:778-5.
25. Brack-Werner R, Kleinschmidt A, Ludvigsen A, et al. Infection of human brain cells by HIV-1: restricted virus production in chronically infected human glial cell lines. AIDS 1992;6:273-85.
26. Squire LR, Zola SM. Structure and function of declarative and nondeclarative memory systems. Proc Natl Acad Sci USA 1996; 93:13515-22.
27. Pang S, Koyanagi Y, Miles S, Wiley C, Vinters HV, Chen IS. High levels of unintegrated HIV-1 DNA in brain tissue of AIDS dementia patients. Nature 1990;343:85-9.
28. Bell JE, Donaldson YK, Lowrie S, et al. Influence of risk group and zidovudine therapy on the development of HIV encephalitis and cognitive impairment in AIDS patients. AIDS 1996;10:493-9.
29. Johnson RT, Glass JD, McArthur JC, Chesebro BW. Quantitation of human immunodeficiency virus in brains of demented and non-demented patients with acquired immunodeficiency syndrome. Ann Neurol 1996;39:392-5.
30. An SF, Giometto B, Scaravilli F. HIV-1 DNA in brains in AIDS and pre-AIDS: correlation with the stage of disease. Ann Neurol 1996;40:611-7.
31. Boni J, Emmerich BS, Leib SL, Wiestler OD, Schupbach J, Kleihues P. PCR identification of HIV-1 DNA sequences in brain tissue of patients with AIDS encephalopathy. Neurology 1993;43: 1813-7.
32. Di Stefano M, Gray F, Leitner T, Chiodi F. Analysis of ENV V3 sequences from HIV-1-infected brain indicates restrained virus expression throughout the disease. J Med Virol 1996;49:41-8.
33. Achim, CL, Wang R, Miners DK, Wiley, CA. Brain viral burden in HIV infection J Neuropathol Exp Neurol 1994;53:284-94.
34. Bockstahler, L, Werner, T, Festl, H, et al. Distribution of HIV genomic DNA in brains of AIDS patients. Clin Diagn Virol 1995; 3:61-72.
35. Achim CL, Masliah E, Heyes MP, et al. Macrophage activation factors in the brains of AIDS patients. J Neuro-AIDS 1996;1:1-16.
36. Masliah E, Achim CL, Ge N, DeTeresa R, Terry RD, Wiley CA. Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol 1992;32:321-9.
37. Wiley CA, Masliah E, Achim CL. Measurement of CNS HIV burden and its association with neurologic damage. Adv Neuroimmunol 1994;4:319-25.
38. Kieburtz D, Ketonen L, Cox C, et al. Cognitive performance and regional brain volume in human immunodeficiency virus type 1 infection. Arch Neurol 1996;53:155-8.